Cargando…

A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples

OBJECTIVE: The use of performance enhancing substances is banned in sports by the World Anti-Doping Agency (WADA). Though most prohibited substances can be detected by GC/MS, inclusion of corticosteroids and designer drugs has made it essential to detect these critical doping agents on LC/MS/MS due...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, I. Madhusudhana, Beotra, Alka, Jain, S., Ahi, S.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841238/
https://www.ncbi.nlm.nih.gov/pubmed/20336223
http://dx.doi.org/10.4103/0253-7613.51347
_version_ 1782179095545643008
author Reddy, I. Madhusudhana
Beotra, Alka
Jain, S.
Ahi, S.
author_facet Reddy, I. Madhusudhana
Beotra, Alka
Jain, S.
Ahi, S.
author_sort Reddy, I. Madhusudhana
collection PubMed
description OBJECTIVE: The use of performance enhancing substances is banned in sports by the World Anti-Doping Agency (WADA). Though most prohibited substances can be detected by GC/MS, inclusion of corticosteroids and designer drugs has made it essential to detect these critical doping agents on LC/MS/MS due to their better separation and detection. MATERIALS AND METHODS: A common extraction procedure for the isolation of acidic, basic and neutral drugs from urine samples was developed. A total of 28 doping drugs were analyzed on API 3200 Triple quadrupole mass spectrometer using C18 column in atmospheric pressure electrospray ionization. The mobile phase composition was a mixture of 1% formic acid and acetonitrile with gradient time period. RESULTS: The method developed was very sensitive for detection of 28 doping agents. The linearity was performed for each drug and the total recovery percentage ranged from 57 to 114. Limit of detection is found to be 0.5 ng/ml for carboxy finasteride and 1-5 ng/ml for other drugs. The method was successfully used to detect positive urine samples of 3-OH-stanozolol, methyl phenidate, mesocarb, clomiphene metabolite and carboxy finasteride. CONCLUSION: The method developed based on controlled pH extraction method and HPLC-mass spectrometry analysis allowed better identification and confirmation of glucocorticosteroids and a few other drugs in different categories. The validated method has been used successfully for testing of 1000 In-competition samples. The method helped in detection of chemically and pharmacologically different banned drugs in urine in a single short run at a minimum required performance limit set by WADA.
format Text
id pubmed-2841238
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28412382010-03-24 A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples Reddy, I. Madhusudhana Beotra, Alka Jain, S. Ahi, S. Indian J Pharmacol Research Article OBJECTIVE: The use of performance enhancing substances is banned in sports by the World Anti-Doping Agency (WADA). Though most prohibited substances can be detected by GC/MS, inclusion of corticosteroids and designer drugs has made it essential to detect these critical doping agents on LC/MS/MS due to their better separation and detection. MATERIALS AND METHODS: A common extraction procedure for the isolation of acidic, basic and neutral drugs from urine samples was developed. A total of 28 doping drugs were analyzed on API 3200 Triple quadrupole mass spectrometer using C18 column in atmospheric pressure electrospray ionization. The mobile phase composition was a mixture of 1% formic acid and acetonitrile with gradient time period. RESULTS: The method developed was very sensitive for detection of 28 doping agents. The linearity was performed for each drug and the total recovery percentage ranged from 57 to 114. Limit of detection is found to be 0.5 ng/ml for carboxy finasteride and 1-5 ng/ml for other drugs. The method was successfully used to detect positive urine samples of 3-OH-stanozolol, methyl phenidate, mesocarb, clomiphene metabolite and carboxy finasteride. CONCLUSION: The method developed based on controlled pH extraction method and HPLC-mass spectrometry analysis allowed better identification and confirmation of glucocorticosteroids and a few other drugs in different categories. The validated method has been used successfully for testing of 1000 In-competition samples. The method helped in detection of chemically and pharmacologically different banned drugs in urine in a single short run at a minimum required performance limit set by WADA. Medknow Publications 2009-04 /pmc/articles/PMC2841238/ /pubmed/20336223 http://dx.doi.org/10.4103/0253-7613.51347 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Reddy, I. Madhusudhana
Beotra, Alka
Jain, S.
Ahi, S.
A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title_full A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title_fullStr A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title_full_unstemmed A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title_short A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples
title_sort simple and rapid esi-lc-ms/ms method for simultaneous screening of doping agents in urine samples
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841238/
https://www.ncbi.nlm.nih.gov/pubmed/20336223
http://dx.doi.org/10.4103/0253-7613.51347
work_keys_str_mv AT reddyimadhusudhana asimpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT beotraalka asimpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT jains asimpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT ahis asimpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT reddyimadhusudhana simpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT beotraalka simpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT jains simpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples
AT ahis simpleandrapidesilcmsmsmethodforsimultaneousscreeningofdopingagentsinurinesamples